卡培他滨联合干扰素-α和白介素-2一线治疗转移性肾癌
出处
《临床肿瘤学杂志》
CAS
2007年第9期697-699,共3页
Chinese Clinical Oncology
参考文献7
-
1de Vita VTJ,Hellman S,Rosenberg SA,et al.Cancer principles and practice of oncology[M].6th ed.Philadelphia:Lippincott Williams & Wilkins,2001:1140-1168.
-
2Therasse P,Arbuck SC,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors[J].J Nafl Cancer Inst,2000,92(3):205-216.
-
3Lopez-Beltran A,Montironi R,Kirkali Z,et al.2004 WHO classification of the renal tumors of the adults[J].European Urology,2006,49:798-805.
-
4Christine M.Capecitabine:A review[J].Clinical Therapeutics,2005,27(1):23-44.
-
5Padrik P,Leppik K,Arak A.A phase Ⅱ study of combination therapy with capecitabine and interferon alfa2A in patients with metastatic renal cell carcinoma[J].Proc Am Soc Clin Oncol,2003,22:1626.
-
6叶定伟,方银忠,戴波,张海梁,沈益君.卡培他滨联合α-干扰素治疗转移性肾癌[J].临床泌尿外科杂志,2004,19(7):429-430. 被引量：2
-
7Wenzel C,Schmidinger MP,Locker GJ,et al.Oral chemotherapy with capecitabine(Xeloda) in the treatment of metastatic renal cancer failing immunotherapy[J].Proc Am Soc Clin Oncol,2000,19:368a.
二级参考文献4
-
1Ellerhorst J A, Sella A, Amato R J, et al. Phase Ⅱ trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma. Cancer, 1997, 80: 2128-2132.
-
2Ishikawa T, Sekiguchi F, Fukase Y, et al. Antitumor activities of a novel fluoropyrimidine, N4-pentyloxycarbonyl-5′-deoxy-5-fluorocytidine ( capecitabine ). Biol Pharm Bull, 1998, 21: 713-717.
-
3Wenzel C, Schmidinger M P, Locker G J, et al. Oral chemotherapy with capecitabineXeloda) in the treatment of metastatic renal cancer failing immunotherapy. Proc Am Soc Clin Oncol, 2000, 19: 368a-368a.
-
4Oevermann K, Buer J, Hoffmann R, et al. Capecitabine in the treatment of metastatic renal cell carcinoma. Br J of Cancer,2000,83: 583-587.
-
1程鑫,姜丽丽,隋英忠.晚期转移性肾癌的靶向治疗研究进展[J].药品评价,2012,9(15):20-23. 被引量：4
-
2孙宝刚,赵林.索拉非尼序贯苏尼替尼治疗晚期转移性肾癌1例[J].中国煤炭工业医学杂志,2011,14(6):882-882. 被引量：1
-
3张海梁,叶定伟.晚期转移性肾癌的治疗[J].国外医学（泌尿系统分册）,2005,25(1):19-23. 被引量：4
-
4冯莉,常靓,刘巍.舒尼替尼治疗转移性肾癌2例报告[J].现代泌尿生殖肿瘤杂志,2012,4(1):46-47.
-
5樊友本,石洪成.逐年高发的甲状腺癌[J].大众医学,2013(8):20-21.
-
6陆星华.胰、胆管癌诊断和治疗的进展[J].中华消化杂志,1999,19(1):8-9. 被引量：4
-
7夏克良.索拉非尼治疗晚期转移性肾癌的现况及展望[J].内蒙古中医药,2010,29(14):110-111. 被引量：2
-
8艾雪松.索拉非尼治疗晚期转移性肾癌的现况及展望[J].中国临床研究,2010,23(7):635-636.
-
9石黑龙.23例晚期转移性肾癌的靶向治疗[J].世界最新医学信息文摘,2013(1):262-262.
-
10帕洛克·迪力木拉提,王文光,哈木拉提·吐送,王玉杰.索拉非尼治疗晚期转移性肾癌的临床疗效分析[J].中华泌尿外科杂志,2014,35(8):639-639. 被引量：3
